Advertisement

Pancreatic Endocrine Tumors

  • David C. Chhieng
  • Edward B. Stelow
Part of the Essentials in Cytopathology book series (EICP, volume 3)

Abstract

Pancreatic endocrine tumors (PETs) are uncommon, accounting for 2% of all pancreatic neoplasms. Previously, it had been noted that somewhere between 60% to 85% of PETs were functioning tumors and were associated with a variety of clinical syndromes (Table 8-1). In today’s world, this no longer is true, and PETs often present without clinical syndromes, often identified incidentally by radiologic imaging. Because patients with nonfunctioning PETs are either asymptomatic or present with nonspecific symtpoms, fine needle aspiration (FNA) is often employed as a diagnostic test. It can also be used to establish a diagnosis of metastatic disease.

Keywords

Cytologic Feature Acinar Cell Carcinoma Pancreatic Endocrine Tumor Ancillary Study Plasma Cell Dyscrasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Bret PM, Nicolet V, Labadie M. Percutaneous fine-needle aspiration biopsy of the pancreas. Diagn Cytopathol 1986;2:221–227.PubMedCrossRefGoogle Scholar
  2. Gala I, Atkinson BF, Nicosia RF, Hermann GA. Fine-needle aspiration cytology of idiopathic pancreatic islet cell adenosis. Diagn Cytopathol 1993;9:453–456.PubMedCrossRefGoogle Scholar
  3. Gu M, Ghafari S, Lin F, Ramzy I. Cytological diagnosis of endocrine tumors of the pancreas by endoscopic ultrasound-guided fine-needle aspiration biopsy. Diagn Cytopathol 2005;32:204–210.PubMedCrossRefGoogle Scholar
  4. Nguyen GK. Cytology of hyperplastic endocrine cells of the pancreas in fine needle aspiration biopsy. Acta Cytol 1984; 28:499–502.PubMedGoogle Scholar
  5. Noone TC, Hosey J, Firat Z, Semelka RC. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 2005;19:195–211.PubMedCrossRefGoogle Scholar
  6. Pelosi G, Bresaola E, Bogina G, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27:1124–1134.PubMedCrossRefGoogle Scholar
  7. Solica E, Capella C, Kloppel G. Tumors of the pancreas, Vol. 20. 3rd ed. Washington DC: ARmed Forces Institue of Pathology; 1997.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • David C. Chhieng
    • 1
  • Edward B. Stelow
    • 2
  1. 1.Department of PathologyUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of PathologyUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations